CD44 and liver cancer: Csn6LKO mice also showed less tumors, smaller tumor size, smaller ratios of liver/body weight and decreased liver cancer markers expression, such as CD44 and ALDHA, when compared with Csn6fl/fl mice (Figure 1I–K).